Blood test ratios may offer cheaper way to track colitis
NCT ID NCT07261579
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether simple blood test ratios, like CRP-to-albumin, can help monitor disease activity in people with ulcerative colitis. Researchers compared these blood markers to standard colonoscopy and symptom scores in 80 patients. The goal was to find a less invasive, cost-effective way to track inflammation and disease severity.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- C-Reactive Protein (CRP) and related blood test ratios
- What this could lead to
- If successful, this could lead to a simpler, cheaper way to monitor ulcerative colitis severity using routine blood tests instead of invasive colonoscopies.
- What could go wrong
- This is a small, completed study (80 people) that only looked at correlations, not a treatment. The findings may not apply to all patients or replace standard monitoring methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Alexandria Faculty of medicine
Alexandria, El Alexandria, 21512, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Sound waves vs. scope: a gentler way to spot pouch inflammation?
- Can we predict how kids with IBD will respond to treatment?
- Can switching IBD meds heal the gut when symptoms are quiet?
- Can a milk sugar tame IBD symptoms?
- Could an extra flu shot shield vulnerable kids?
- Can a glass of pomegranate juice tame gut inflammation?